Who Owns Conmed Corp
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Conmed Corp.
Who crossed 5% of CNMD →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| EPIQ PARTNERS, LLCCOM15.1K shheld | $696.2K |
| Fenimore Asset Management IncCOM8.9K shheld | $411.5K |
| GAMMA Investing LLCCommon Stock911 shadded | $42.1K |
| Farther Finance Advisors, LLCStock463 shadded | $21.4K |
| Investors Research CorpCOM415 shheld | $19.2K |
| CoreCap Advisors, LLCStock33 shheld | $1.5K |
| MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock5 shheld | $231 |
| Davis Capital ManagementStock2 shheld | $92 |
| GILPIN WEALTH MANAGEMENT, LLCCOM1 shtrimmed | $47 |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on CNMD
Follow Conmed Corp (CNMD) by email
New trades in Conmed Corp (CNMD) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.